ORIC-I: Optimizing Recovery From Intensive Care: Mechanical Ventilation and Delirium



Status:Completed
Conditions:Neurology, Psychiatric
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:3/12/2016
Start Date:March 2006
End Date:December 2010
Contact:Barbara J Early, BSN
Email:earlybj@upmc.edu
Phone:412 647 9745

Use our guide to learn which trials are right for you!

The purpose of this study is to determine if treating delirious intensive care unit patients
with haloperidol improves mortality.

Intensive care unit delirium is a serious medical condition that is associated with
increased morbidity and mortality. In this study, 304 delirious mechanically ventilated
subjects will be randomized to haloperidol 5mg IV every 12 hours or placebo to determine if
treatment with haloperidol improves short and long-term mortality.

Inclusion Criteria:

- All adult (>=18 years of age) mechanically ventilated patients admitted to the
medical, surgical, trauma, or cardiothoracic ICUs of the UPMC main campus who are
expected by the ICU clinical team to require >24 hours of mechanical ventilation

Exclusion Criteria:

- Baseline QTc >480 milliseconds (ms); history of Parkinson's disease; pregnancy;
history of schizophrenia or neurologic disease that would confound the delirium
assessment; deafness or inability to understand English or Spanish; extubation prior
to enrollment; previously enrolled in this study; patient, family, or attending
physician refusal; death before enrollment; treatment with haloperidol within 2 days
prior to ICU admission; and prisoners.
We found this trial at
1
site
Pittsburgh, Pennsylvania 15261
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials